StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$1.28+0.09 (+7.56%)

Close on Nov 13, 2026Market cap $22.51MP/E –Yield –

Cel Sci pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cel Sci's pe ratio was 13.5× on Apr 29, 2011.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2011Apr 29, 201113.5×−2.5
2010Dec 31, 201016.0×–

More Cel Sci figures

See a number that looks wrong?